A powerful approach to identify replicable variants in genome-wide association studies Y Li, H Lei, X Wen, H Cao The American Journal of Human Genetics 111 (5), 966-978, 2024 | | 2024 |
A powerful empirical Bayes approach for high dimensional replicability analysis H Lei, Y Li, H Cao arXiv preprint arXiv:2310.09701, 2023 | | 2023 |
A powerful replicability analysis of genome-wide association studies Y Li, H Lei, X Wen, H Cao medRxiv, 2023.09. 04.23295018, 2023 | | 2023 |
A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up RH Grogan, SP Kaplan, H Cao, RE Weiss, LJ DeGroot, CA Simon, ... Surgery 154 (6), 1436-1447, 2013 | 296 | 2013 |
Analysis of asynchronous longitudinal data with partially linear models L Chen, H Cao Electronic Journal of Statistics 11 (1), 1549-1569, 2017 | 15 | 2017 |
Analysis of the proportional hazards model with sparse longitudinal covariates H Cao, MM Churpek, D Zeng, JP Fine Journal of the American Statistical Association 110 (511), 1187-1196, 2015 | 32 | 2015 |
Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer MT Spiotto, H Cao, L Mell, FG Toback Anti-cancer drugs 26 (3), 343-349, 2015 | 8 | 2015 |
Array Platform Modeling and Analysis (A) LX Qin, S Ma, YT Huang, H Zhang, H Cao Cancer Informatics 13, CIN. S22973, 2014 | | 2014 |
Assessing agreement with multiple raters on correlated kappa statistics H Cao, PK Sen, AF Peery, ES Dellon Biometrical Journal 58 (4), 935-943, 2016 | 27 | 2016 |
Assessing non-inferiority for incomplete paired-data under non-ignorable missing mechanism H Li, G Tian, N Tang, H Cao Computational statistics & data analysis 127, 69-81, 2018 | 1 | 2018 |
Background: Several (neo) adjuvant treatments for patients with HER2-positive breast cancer have been compared in different randomized clinical trials. Since it is not feasible … M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ... Frontiers in Oncology 8 (156), 1, 2018 | | 2018 |
Changepoint estimation: another look at multiple testing problems H Cao, W Biao Wu Biometrika 102 (4), 974-980, 2015 | 31 | 2015 |
Changes in childhood diarrhea incidence in nicaragua following 3 years of universal infant rotavirus immunization S Becker-Dreps, M Paniagua, R Dominik, H Cao, NK Shah, DR Morgan, ... The Pediatric infectious disease journal 30 (3), 243-247, 2011 | 32 | 2011 |
Clinical evaluation of cisplatin sensitivity germ line polymorphisms in neoadjuvant chemotherapy (NAC) for urothelial cancer (UC). PH O'Donnell, IR Garcia-Grossman, H Cao, I Ostrovnaya, ER Plimack, ... Journal of Clinical Oncology 32 (4_suppl), 342-342, 2014 | | 2014 |
Clinical evaluation of cisplatin sensitivity of germline polymorphisms in neoadjuvant chemotherapy for urothelial cancer PH O’Donnell, S Alanee, KL Stratton, IR Garcia-Grossman, H Cao, ... Clinical genitourinary cancer 14 (6), 511-517, 2016 | 8 | 2016 |
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant CR Petri, PH O’Donnell, H Cao, AS Artz, W Stock, A Wickrema, M Hard, ... Leukemia & lymphoma 55 (12), 2866-2873, 2014 | 18 | 2014 |
Combining protein sequences and structures with transformers and equivariant graph neural networks to predict protein function JC Frimpong Boadu, Hongyuan Cao Bioinformatics 39, i318-i325, 2023 | 17 | 2023 |
Combining protein sequences and structures with transformers and equivariant graph neural networks to predict protein function JC Frimpong Boadu, Hongyuan Cao Bioinformatics, 0 | | |
Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: a network meta-analysis M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ... Frontiers in Oncology 8, 156, 2018 | 36 | 2018 |
Evaluating two PTI test procedures for control of delivered dose uniformity for aerosol products Y Lan, CT Lin, H Cao Statistics in Biopharmaceutical Research 4 (2), 136-148, 2012 | 1 | 2012 |